BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Clinical & Diagnostic

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

March 14, 2023 | News

Qritive and Corista Partner to Advance Computational Digital Pathology Workflows with Integrated Image Management"

Through the partnership, Qritive's artificial intelligence modules and Corista's DP3® image management platform will be integrated to help pathologist'...

March 14, 2023 | News

Everest Medicines' Partner Calliditas Reports Positive Phase 3 Results for Nefecon in IgA Nephropathy Trial

The trial met its primary endpoint with Nefecon demonstrating a highly statistically significant benefit over placebo (p value < 0.0001) in estimated gl...

March 14, 2023 | News

AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.

Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...

March 13, 2023 | News

Allorion Therapeutics Raises $50M in Series B Financing for Precision Medicine in Oncology and Autoimmune Diseases

The funds raised in this round will primarily support upcoming Phase I/II clinical trials in both China and the U.S. and the identification of cl...

March 11, 2023 | News

Leica Microsystems and Mentoring Hessen seal partnership

Leica Microsystems, a leader in microscopy and scientific instrumentation, has entered a partnership with Mentoring Hessen and strengthened its efforts to ...

March 09, 2023 | News

IIVS and Toxys Enter into Agreement to Offer ToxTracker® for In Vitro Genetic Toxicity Evaluation

The Institute for In Vitro Sciences (IIVS) and Toxys have entered into a license agreement that allows IIVS to offer the ToxTracker®...

March 09, 2023 | News

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cance...

March 07, 2023 | News

C2i Genomics Expands to Japan, Announces Collab with Riken Genesis

The collaboration will expand C2i’s global reach and bring MRD cancer monitoring capabilities for solid tumors to Japan C2i Genomics...

March 03, 2023 | News

Kevzara® (sarilumab) Approved by FDA as First and Only Biologic Indicated for Patients with Polymyalgia Rheumatica

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Kevzara® (...

March 01, 2023 | News

Gene Solutions' Latest Update: Promising Multi-Cancer Early Detection in Southeast Asia

Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...

March 01, 2023 | News

GSK educates Singaporeans on shingles protection during Awareness Week.

A GSK-sponsored Ipsos-MORI survey revealed only 3% of Singaporeans aged 50-79 years believe they are at high risk of developing shingles in the next 12 mon...

February 28, 2023 | News

GC Biopharma Acquires Catalyst Biosciences' Rare Disease Pipeline in Hematology

GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that it has signed an Asset Purchase ...

February 28, 2023 | News

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

The clinical trial to be conducted by Peter Mac will be the first time a CAR-T cell therapy product containing the genetic modifications incorporated into ...

February 27, 2023 | News

Stay Connected